122 related articles for article (PubMed ID: 14689588)
1. Fingerprinting the diseased prostate: associations between BPH and prostate cancer.
Shah US; Getzenberg RH
J Cell Biochem; 2004 Jan; 91(1):161-9. PubMed ID: 14689588
[TBL] [Abstract][Full Text] [Related]
2. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.
Luo J; Duggan DJ; Chen Y; Sauvageot J; Ewing CM; Bittner ML; Trent JM; Isaacs WB
Cancer Res; 2001 Jun; 61(12):4683-8. PubMed ID: 11406537
[TBL] [Abstract][Full Text] [Related]
3. [Differentially expressed genes in prostate cancer and benign prostatic hyperplasia].
Zhang T; Xu Y; Tang H; Liu M; Ren D; Niu Y
Zhonghua Nan Ke Xue; 2004 Dec; 10(12):897-9. PubMed ID: 15638016
[TBL] [Abstract][Full Text] [Related]
4. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
5. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.
Salam MT; Ursin G; Skinner EC; Dessissa T; Reichardt JK
Urol Oncol; 2005; 23(4):246-53. PubMed ID: 16018939
[TBL] [Abstract][Full Text] [Related]
6. A quantitative promoter methylation profile of prostate cancer.
Jerónimo C; Henrique R; Hoque MO; Mambo E; Ribeiro FR; Varzim G; Oliveira J; Teixeira MR; Lopes C; Sidransky D
Clin Cancer Res; 2004 Dec; 10(24):8472-8. PubMed ID: 15623627
[TBL] [Abstract][Full Text] [Related]
7. Regulation of expression of the early growth response gene-1 (EGR-1) in malignant and benign cells of the prostate.
Mora GR; Olivier KR; Mitchell RF; Jenkins RB; Tindall DJ
Prostate; 2005 May; 63(2):198-207. PubMed ID: 15486985
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of macrophage inhibitory cytokine-1/prostate derived factor in benign prostatic hyperplasia.
Kakehi Y; Segawa T; Wu XX; Kulkarni P; Dhir R; Getzenberg RH
Prostate; 2004 Jun; 59(4):351-6. PubMed ID: 15065082
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profile in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia.
Alonso V; Neves AF; Marangoni K; Faria PC; Freschi AP; Capaneli AC; Meola J; Goulart LR
Cancer Detect Prev; 2009; 32(4):336-7. PubMed ID: 19026495
[TBL] [Abstract][Full Text] [Related]
10. Evidence of a novel biomarker, alphas1-Casein, a milk protein, in benign prostate hyperplasia.
Xu K; Ling MT; Wang X; Wong YC
Prostate Cancer Prostatic Dis; 2006; 9(3):293-7. PubMed ID: 16683014
[TBL] [Abstract][Full Text] [Related]
11. Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer.
Rose A; Xu Y; Chen Z; Fan Z; Stamey TA; McNeal JE; Caldwell M; Peehl DM
Cancer Lett; 2005 Sep; 227(2):213-22. PubMed ID: 16112424
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression profiling in prostate cancer.
Porkka KP; Pfeiffer MJ; Waltering KK; Vessella RL; Tammela TL; Visakorpi T
Cancer Res; 2007 Jul; 67(13):6130-5. PubMed ID: 17616669
[TBL] [Abstract][Full Text] [Related]
13. Down's syndrome-associated single minded gene as a novel tumor marker.
Deyoung MP; Scheurle D; Damania H; Zylberberg C; Narayanan R
Anticancer Res; 2002; 22(6A):3149-57. PubMed ID: 12530058
[TBL] [Abstract][Full Text] [Related]
14. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
Zhigang Z; Wenlu S
Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 17 is over-expressed in human prostate cancer.
Heer R; Douglas D; Mathers ME; Robson CN; Leung HY
J Pathol; 2004 Dec; 204(5):578-86. PubMed ID: 15538740
[TBL] [Abstract][Full Text] [Related]
16. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J
Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679
[TBL] [Abstract][Full Text] [Related]
17. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
18. HMGA2 expression in a canine model of prostate cancer.
Winkler S; Murua Escobar H; Meyer B; Simon D; Eberle N; Baumgartner W; Loeschke S; Nolte I; Bullerdiek J
Cancer Genet Cytogenet; 2007 Sep; 177(2):98-102. PubMed ID: 17854662
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
Soulitzis N; Karyotis I; Delakas D; Spandidos DA
Int J Oncol; 2006 Aug; 29(2):305-14. PubMed ID: 16820871
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer.
Leskelä S; Honrado E; Montero-Conde C; Landa I; Cascón A; Letón R; Talavera P; Cózar JM; Concha A; Robledo M; Rodríguez-Antona C
Endocr Relat Cancer; 2007 Sep; 14(3):645-54. PubMed ID: 17914095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
